167 related articles for article (PubMed ID: 16109371)
1. Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl.
Hantschel O; Wiesner S; Güttler T; Mackereth CD; Rix LL; Mikes Z; Dehne J; Görlich D; Sattler M; Superti-Furga G
Mol Cell; 2005 Aug; 19(4):461-73. PubMed ID: 16109371
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the c-Abl and Bcr-Abl tyrosine kinases.
Hantschel O; Superti-Furga G
Nat Rev Mol Cell Biol; 2004 Jan; 5(1):33-44. PubMed ID: 14708008
[TBL] [Abstract][Full Text] [Related]
3. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
Buffa P; Manzella L; Consoli ML; Messina A; Vigneri P
Proteins; 2007 Apr; 67(1):1-11. PubMed ID: 17211892
[TBL] [Abstract][Full Text] [Related]
4. Cysteine scanning mutagenesis at 40 of 76 positions in villin headpiece maps the F-actin binding site and structural features of the domain.
Doering DS; Matsudaira P
Biochemistry; 1996 Oct; 35(39):12677-85. PubMed ID: 8841111
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements of tropomodulin for tropomyosin binding and actin filament capping.
Kostyukova AS; Rapp BA; Choy A; Greenfield NJ; Hitchcock-DeGregori SE
Biochemistry; 2005 Mar; 44(12):4905-10. PubMed ID: 15779917
[TBL] [Abstract][Full Text] [Related]
6. Interplay between kinase domain autophosphorylation and F-actin binding domain in regulating imatinib sensitivity and nuclear import of BCR-ABL.
Preyer M; Vigneri P; Wang JY
PLoS One; 2011 Feb; 6(2):e17020. PubMed ID: 21347248
[TBL] [Abstract][Full Text] [Related]
7. Structure of the Bcr-Abl oncoprotein oligomerization domain.
Zhao X; Ghaffari S; Lodish H; Malashkevich VN; Kim PS
Nat Struct Biol; 2002 Feb; 9(2):117-20. PubMed ID: 11780146
[TBL] [Abstract][Full Text] [Related]
8. NMR structure of an F-actin-binding "headpiece" motif from villin.
Vardar D; Buckley DA; Frank BS; McKnight CJ
J Mol Biol; 1999 Dec; 294(5):1299-310. PubMed ID: 10600386
[TBL] [Abstract][Full Text] [Related]
9. Properties of an ezrin mutant defective in F-actin binding.
Saleh HS; Merkel U; Geissler KJ; Sperka T; Sechi A; Breithaupt C; Morrison H
J Mol Biol; 2009 Jan; 385(4):1015-31. PubMed ID: 19084535
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic treatment (ALA-PDT) suppresses the expression of the oncogenic Bcr-Abl kinase and affects the cytoskeleton organization in K562 cells.
Pluskalová M; Peslová G; Grebenová D; Halada P; Hrkal Z
J Photochem Photobiol B; 2006 Jun; 83(3):205-12. PubMed ID: 16495075
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
12. Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.
Yi SJ; Lee HT; Groffen J; Heisterkamp N
Int J Mol Med; 2008 Oct; 22(4):453-8. PubMed ID: 18813851
[TBL] [Abstract][Full Text] [Related]
13. Structure of severin domain 2 in solution.
Schnuchel A; Wiltscheck R; Eichinger L; Schleicher M; Holak TA
J Mol Biol; 1995 Mar; 247(1):21-7. PubMed ID: 7897658
[TBL] [Abstract][Full Text] [Related]
14. F-actin-binding domain of c-Abl regulates localized phosphorylation of C3G: role of C3G in c-Abl-mediated cell death.
Mitra A; Radha V
Oncogene; 2010 Aug; 29(32):4528-42. PubMed ID: 20581864
[TBL] [Abstract][Full Text] [Related]
15. Normal c-abl gene protein--a nuclear component.
Dhut S; Chaplin T; Young BD
Oncogene; 1991 Aug; 6(8):1459-64. PubMed ID: 1886716
[TBL] [Abstract][Full Text] [Related]
16. Imatinib mesylate (STI571)-induced cell edge translocation of kinase-active and kinase-defective Abelson kinase: requirements of myristoylation and src homology 3 domain.
Fujita A; Shishido T; Yuan Y; Inamoto E; Narumiya S; Watanabe N
Mol Pharmacol; 2009 Jan; 75(1):75-84. PubMed ID: 18835981
[TBL] [Abstract][Full Text] [Related]
17. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of murine coronin-1: a regulator of actin cytoskeletal dynamics in lymphocytes.
Appleton BA; Wu P; Wiesmann C
Structure; 2006 Jan; 14(1):87-96. PubMed ID: 16407068
[TBL] [Abstract][Full Text] [Related]
19. Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.
Underhill-Day N; Pierce A; Thompson SE; Xenaki D; Whetton AD; Owen-Lynch PJ
Br J Haematol; 2006 Mar; 132(6):774-83. PubMed ID: 16487179
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
